Literature DB >> 25962626

Geometric Verification of Dynamic Wave Arc Delivery With the Vero System Using Orthogonal X-ray Fluoroscopic Imaging.

Manuela Burghelea1, Dirk Verellen2, Kenneth Poels2, Thierry Gevaert2, Tom Depuydt3, Koen Tournel2, Cecilia Hung4, Viorica Simon5, Masahiro Hiraoka5, Mark de Ridder2.   

Abstract

PURPOSE: The purpose of this study was to define an independent verification method based on on-board orthogonal fluoroscopy to determine the geometric accuracy of synchronized gantry-ring (G/R) rotations during dynamic wave arc (DWA) delivery available on the Vero system. METHODS AND MATERIALS: A verification method for DWA was developed to calculate O-ring-gantry (G/R) positional information from ball-bearing positions retrieved from fluoroscopic images of a cubic phantom acquired during DWA delivery. Different noncoplanar trajectories were generated in order to investigate the influence of path complexity on delivery accuracy. The G/R positions detected from the fluoroscopy images (DetPositions) were benchmarked against the G/R angulations retrieved from the control points (CP) of the DWA RT plan and the DWA log files recorded by the treatment console during DWA delivery (LogActed). The G/R rotational accuracy was quantified as the mean absolute deviation ± standard deviation. The maximum G/R absolute deviation was calculated as the maximum 3-dimensional distance between the CP and the closest DetPositions.
RESULTS: In the CP versus DetPositions comparison, an overall mean G/R deviation of 0.13°/0.16° ± 0.16°/0.16° was obtained, with a maximum G/R deviation of 0.6°/0.2°. For the LogActed versus DetPositions evaluation, the overall mean deviation was 0.08°/0.15° ± 0.10°/0.10° with a maximum G/R of 0.3°/0.4°. The largest decoupled deviations registered for gantry and ring were 0.6° and 0.4° respectively. No directional dependence was observed between clockwise and counterclockwise rotations. Doubling the dose resulted in a double number of detected points around each CP, and an angular deviation reduction in all cases.
CONCLUSIONS: An independent geometric quality assurance approach was developed for DWA delivery verification and was successfully applied on diverse trajectories. Results showed that the Vero system is capable of following complex G/R trajectories with maximum deviations during DWA below 0.6°.
Copyright © 2015 Elsevier Inc. All rights reserved.

Mesh:

Year:  2015        PMID: 25962626     DOI: 10.1016/j.ijrobp.2015.02.053

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Monitoring of mechanical errors and their dosimetric impact throughout the course of non-coplanar continuous volumetric-modulated arc therapy.

Authors:  Hideaki Hirashima; Mitsuhiro Nakamura; Yuki Miyabe; Megumi Uto; Kiyonao Nakamura; Takashi Mizowaki
Journal:  Radiat Oncol       Date:  2018-02-14       Impact factor: 3.481

Review 2.  Recent developments in non-coplanar radiotherapy.

Authors:  Gregory Smyth; Philip M Evans; Jeffrey C Bamber; James L Bedford
Journal:  Br J Radiol       Date:  2019-02-01       Impact factor: 3.039

Review 3.  Novel methodologies for dosimetry audits: Adapting to advanced radiotherapy techniques.

Authors:  Marlies Pasler; Victor Hernandez; Núria Jornet; Catharine H Clark
Journal:  Phys Imaging Radiat Oncol       Date:  2018-03-19

4.  Initial characterization, dosimetric benchmark and performance validation of Dynamic Wave Arc.

Authors:  Manuela Burghelea; Dirk Verellen; Kenneth Poels; Cecilia Hung; Mitsuhiro Nakamura; Jennifer Dhont; Thierry Gevaert; Robbe Van den Begin; Christine Collen; Yukinori Matsuo; Takahiro Kishi; Viorica Simon; Masahiro Hiraoka; Mark de Ridder
Journal:  Radiat Oncol       Date:  2016-04-29       Impact factor: 3.481

5.  Quality assurance of geometric accuracy based on an electronic portal imaging device and log data analysis for Dynamic WaveArc irradiation.

Authors:  Hideaki Hirashima; Yuki Miyabe; Mitsuhiro Nakamura; Nobutaka Mukumoto; Takashi Mizowaki; Masahiro Hiraoka
Journal:  J Appl Clin Med Phys       Date:  2018-04-06       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.